IRTC

IRTC

USD

iRhythm Technologies Inc. Common Stock

$181.100-1.580 (-0.865%)

实时价格

Healthcare
医疗设备
美国

价格图表

Loading Chart...

关键指标

市场指标
公司基本面
交易统计

市场指标

开盘价

$182.680

最高价

$185.040

最低价

$177.740

成交量

0.37M

公司基本面

市值

5.8B

所属行业

医疗设备

国家/地区

United States

交易统计

平均成交量

0.40M

交易所

NMS

货币

USD

52周价格范围

最低价 $71当前价 $181.100最高价 $212

相关新闻

GlobeNewswire

iRhythm Technologies to Participate in Upcoming Investor Conferences

SAN FRANCISCO, Nov. 04, 2025 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, prevent, and predict disease, today

查看更多
iRhythm Technologies to Participate in Upcoming Investor Conferences
Analyst Upgrades

Canaccord Genuity Maintains Buy on iRhythm Technologies, Raises Price Target to $212

Canaccord Genuity analyst William Plovanic maintains iRhythm Technologies with a Buy and raises the price target from $193 to $212.

查看更多
Canaccord Genuity Maintains Buy on iRhythm Technologies, Raises Price Target to $212
Analyst Upgrades

Citigroup Maintains Buy on iRhythm Technologies, Raises Price Target to $242

Citigroup analyst Joanne Wuensch maintains iRhythm Technologies with a Buy and raises the price target from $205 to $242.

查看更多
Citigroup Maintains Buy on iRhythm Technologies, Raises Price Target to $242
Analyst Upgrades

JP Morgan Maintains Overweight on iRhythm Technologies, Raises Price Target to $240

JP Morgan analyst Allen Gong maintains iRhythm Technologies with a Overweight and raises the price target from $190 to $240.

查看更多
JP Morgan Maintains Overweight on iRhythm Technologies, Raises Price Target to $240
Analyst Upgrades

iRhythm Well-Positioned For 2026 After Upbeat Results And Raised Outlook

iRhythm Technologies beat Q3 estimates with record revenue, raised its 2025 sales outlook, and gained analyst confidence with higher price targets.

查看更多
iRhythm Well-Positioned For 2026 After Upbeat Results And Raised Outlook
Analyst Upgrades

Goldman Sachs Maintains Neutral on iRhythm Technologies, Raises Price Target to $202

Goldman Sachs analyst David Roman maintains iRhythm Technologies with a Neutral and raises the price target from $180 to $202.

Analyst Upgrades

Needham Maintains Buy on iRhythm Technologies, Raises Price Target to $244

Needham analyst David Saxon maintains iRhythm Technologies with a Buy and raises the price target from $193 to $244.